COST OF BEST SUPPORTIVE CARE IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIATIC ARTHRITIS IN THE UNITED STATES

被引：0
|
作者：
Tencer, T. [1 ]
Li, S. [2 ]
Zhang, F. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
[2] Celgene Corp, Warren, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A222 / A222
页数：1
相关论文
共 50 条
  • [21] Return to driving after moderate-to-severe TBI in the United States
    Novack, Thomas
    Zhang, Yue
    Kennedy, Richard
    Bergquist, Thomas
    Walker, William
    Rapport, Lisa
    Dreer, Laura
    Bombardier, Charles
    Goldin, Yelena
    Tefertiller, Candy
    Watanabe, Thomas
    Mahoney, Elaine
    Marwitz, Jennifer
    Brunner, Robert
    BRAIN INJURY, 2023, 37 : 21 - 21
  • [22] Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
    Armuzzi, Alessandro
    DiBonaventura, Marco daCosta
    Tarallo, Miriam
    Lucas, James
    Bluff, Daniel
    Hoskin, Benjamin
    Bargo, Danielle
    Cappelleri, Joseph C.
    Quirk, Daniel
    Salese, Leonardo
    PLOS ONE, 2020, 15 (01):
  • [23] The Treatment of Moderate-to-Severe Psoriasis: Prescreening and Monitoring Psoriatic Patients on Biologics
    Levine, Danielle
    Strober, Bruce E.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 28 - 34
  • [24] COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN SPAIN
    Schweikert, B.
    Storck, C. T.
    Nunez, M.
    Dilla, T.
    Hartz, S.
    Sapin, C.
    VALUE IN HEALTH, 2018, 21 : S319 - S319
  • [25] Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
    Schweikert, Bernd
    Malmberg, Chiara
    Nunez, Mercedes
    Dilla, Tatiana
    Sapin, Christophe
    Hartz, Susanne
    BMJ OPEN, 2020, 10 (08):
  • [26] ECONOMIC EVALUATION OF DUPILUMAB VERSUS STANDARD OF CARE FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE-TO-SEVERE PRURIGO NODULARIS IN THE UNITED STATES
    Tavi, J.
    Bahloul, D.
    Kuznik, A.
    Thomas, R. B.
    Knight, C.
    Manga, N.
    Sullivan, S.
    VALUE IN HEALTH, 2024, 27 (12) : S104 - S104
  • [27] COST EFFECTIVENESS ANALYSIS OF SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES
    Bilal, J.
    Urbine, T.
    Saligrama, P. T.
    Khalil, M. J.
    Malone, D. C.
    Bhattacharjee, S.
    VALUE IN HEALTH, 2018, 21 : S294 - S294
  • [28] Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis
    Puig, Luis
    Strohal, Robert
    Husni, M. Elaine
    Tsai, Tsen-Fang
    Noppakun, Nopadon
    Szumski, Annette
    Yang, Shiyi
    Robertson, Deborah
    Boggs, Robert
    Koenig, Andrew S.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (01) : 7 - 15
  • [29] Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients Comorbid with Psoriatic Arthritis
    Feldman, Steven R.
    Zhao, Yang
    Shi, Lizheng
    Lu, Jackie
    Tran, MaryHelen
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S680 - S681
  • [30] INCREMENTAL BURDEN OF CARDIOVASCULAR COMORBIDITY OR PSORIATIC ARTHRITIS AMONG INDIVIDUALS WITH MODERATE-TO-SEVERE PSORIASIS
    Augustin, M.
    Tian, H.
    Gilloteau, I
    Mollon, P.
    Vietri, J.
    VALUE IN HEALTH, 2016, 19 (03) : A126 - A126
12345